164 related articles for article (PubMed ID: 12469328)
1. Investigation of the high partition of YM992, a novel antidepressant, in rat brain - in vitro and in vivo evidence for the high binding in brain and the high permeability at the BBB.
Mano Y; Higuchi S; Kamimura H
Biopharm Drug Dispos; 2002 Dec; 23(9):351-60. PubMed ID: 12469328
[TBL] [Abstract][Full Text] [Related]
2. Microdialysis evaluation of atomoxetine brain penetration and central nervous system pharmacokinetics in rats.
Kielbasa W; Kalvass JC; Stratford R
Drug Metab Dispos; 2009 Jan; 37(1):137-42. PubMed ID: 18936112
[TBL] [Abstract][Full Text] [Related]
3. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding.
Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J
J Pharmacol Exp Ther; 2005 Jun; 313(3):1254-62. PubMed ID: 15743928
[TBL] [Abstract][Full Text] [Related]
4. Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier.
Poduslo JF; Curran GL; Haggard JJ; Biere AL; Selkoe DJ
Neurobiol Dis; 1997; 4(1):27-34. PubMed ID: 9258909
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system distribution kinetics of indinavir in rats.
Hamidi M
J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
[TBL] [Abstract][Full Text] [Related]
6. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
[TBL] [Abstract][Full Text] [Related]
7. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
8. Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies.
Anderson BD; Hoesterey BL; Baker DC; Galinsky RE
J Pharmacol Exp Ther; 1990 Apr; 253(1):113-8. PubMed ID: 2109797
[TBL] [Abstract][Full Text] [Related]
9. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.
Bickel U; Schumacher OP; Kang YS; Voigt K
J Pharmacol Exp Ther; 1996 Jul; 278(1):107-13. PubMed ID: 8764341
[TBL] [Abstract][Full Text] [Related]
10. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
Preston E; Slinn J; Vinokourov I; Stanimirovic D
J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
[TBL] [Abstract][Full Text] [Related]
11. Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis.
Wong SL; Van Belle K; Sawchuk RJ
J Pharmacol Exp Ther; 1993 Feb; 264(2):899-909. PubMed ID: 8437131
[TBL] [Abstract][Full Text] [Related]
12. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: an in vivo microdialysis study.
Song Y; Feng Y; Leblanc MH; Castagloni N; Liu YM
Neurosci Lett; 2006 Feb; 395(1):63-6. PubMed ID: 16289318
[TBL] [Abstract][Full Text] [Related]
13. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method.
Kakee A; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Dec; 283(3):1018-25. PubMed ID: 9399971
[TBL] [Abstract][Full Text] [Related]
14. Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu).
Gupta A; Chatelain P; Massingham R; Jonsson EN; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Feb; 34(2):318-23. PubMed ID: 16303872
[TBL] [Abstract][Full Text] [Related]
15. Facilitated transport of cefodizime into the rat central nervous system.
Matsushita H; Suzuki H; Sugiyama Y; Sawada Y; Iga T; Kawaguchi Y; Hanano M
J Pharmacol Exp Ther; 1991 Nov; 259(2):620-5. PubMed ID: 1941610
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier.
Poduslo JF; Curran GL; Sanyal B; Selkoe DJ
Neurobiol Dis; 1999 Jun; 6(3):190-9. PubMed ID: 10408808
[TBL] [Abstract][Full Text] [Related]
17. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
Boström E; Simonsson US; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
Bundgaard C; Jørgensen M; Larsen F
Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: potential involvement of a carrier-mediated mechanism.
Au-Yeung SC; Rurak DW; Gruber N; Riggs KW
Drug Metab Dispos; 2006 Jun; 34(6):955-60. PubMed ID: 16510542
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system.
Wu D; Pardridge WM
J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
